Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models (Karanika et al, 2026)
Congratulations to Dr. Styliani Karanika, who is a JHU TRAC ESI, Mentee, and Developmental Awardee on this publication in the Journal of Clinical Investigation! The open-access full ...